Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults

ClinicalTrials.gov ID: NCT06237049

Public ClinicalTrials.gov record NCT06237049. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 8:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA COVID-19 Vaccine and a Recombinant Influenza Vaccine Administered as a Single Injection in Healthy Adults 50 Years of Age or Older

Study identification

NCT ID
NCT06237049
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
644 participants

Conditions and interventions

Interventions

  • BNT162b2 (Omi XBB.1.5) Biological
  • BNT162b2 (Omi XBB.1.5)/RIV Biological
  • Normal saline placebo Other
  • RIV Biological

Biological · Other

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 30, 2024
Primary completion
Sep 12, 2024
Completion
Sep 12, 2024
Last update posted
Sep 29, 2025

2024

United States locations

U.S. sites
30
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Orange County Research Center Lake Forest California 92630
Orange County Research Center Tustin California 92780
Diablo Clinical Research, Inc. Walnut Creek California 94598
Clinical Research Consulting Milford Connecticut 06460
GW Medical Faculty Associates Washington D.C. District of Columbia 20037
GW Vaccine Research Unit Washington D.C. District of Columbia 20037
JEM Research Institute Atlantis Florida 33462
Indago Research & Health Center, Inc Hialeah Florida 33012
Optimal Research Melbourne Florida 32934
Headlands Research Orlando Orlando Florida 32819
Clinical Site Partners, LLC dba Flourish Research Winter Park Florida 32789
Clinical Research Atlanta Stockbridge Georgia 30281
East-West Medical Research Institute Honolulu Hawaii 96814
Optimal Research Peoria Illinois 61614
Bio-Kinetic Clinical Applications, LLC dba QPS-MO Springfield Missouri 65802
Bio-Kinetic Clinical Applications, LLD dba QPS-MO Springfield Missouri 65802
Bio-Kinetic Clinical Applications LLC DBA QPS-MO(Patient Screening Center) Springfield Missouri 65807
Las Vegas Clinical Trials Las Vegas Nevada 89030
Las Vegas Clinical Trials North Las Vegas Nevada 89030
ActivMed Practices & Research, LLC. Portsmouth New Hampshire 03801
Rochester Clinical Research, LLC Rochester New York 14609
Centricity Research Columbus Ohio Multispecialty Columbus Ohio 43213
Clinical Research Associates Inc Nashville Tennessee 37203
DM Clinical Research- Cyfair Houston Texas 77065
DM Clinical Research - Bellaire Houston Texas 77081
SMS Clinical Research Mesquite Texas 75149
Clinical Trials of Texas, LLC San Antonio Texas 78229
IMA Clinical Research San Antonio San Antonio Texas 78229
DM Clinical Research - MDC Tomball Texas 77375
Charlottesville Medical Research Charlottesville Virginia 22911

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06237049, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 29, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06237049 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →